CRISPR Therapeutics AG (CRSP) SEC filings
CRSPNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/30
$40.15−0.22 (-0.54%)
Close on Nov 17, 2026Market cap $3.88BP/E –Yield –
SEC filings
40 of CRISPR Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 2, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 2, 2026 | Nov 2, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 19, 2026 | Oct 19, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 4, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 4, 2026 | SEC EDGAR |
| Current report | 8-K | May 4, 2026 | May 4, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 4, 2026 | Apr 21, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 11, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2026 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2025 | Oct 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 4, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2025 | Aug 4, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2025 | Jun 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | May 19, 2025 | May 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2025 | Apr 16, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 26, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 11, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2025 | Feb 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 5, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2024 | Nov 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 5, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2024 | Aug 5, 2024 | SEC EDGAR |
| Current report | 8-K | May 30, 2024 | Jun 3, 2024 | SEC EDGAR |
| Current report | 8-K | May 23, 2024 | May 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 30, 2024 | Apr 9, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 21, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 21, 2024 | Feb 21, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2024 | Feb 13, 2024 | SEC EDGAR |
See a number that looks wrong?